Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

CGEMCGEM
Showing 8 of 22 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in CULLINAN THERAPEUTICS INC

DEUTSCHE BANK AG\ holds 382,840 shares of CGEM (CULLINAN THERAPEUTICS INC), worth $7M as of 2026-Q2. The position was increased (+4.1% shares). CGEM represents 0.0% of DEUTSCHE BANK AG\'s portfolio.

Current Value

$7M

Current Shares

382,840

Total Value Change

-$2.4M

Total Shares Change

-178,033

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
382,840
+4.1%
$7M0.0%$18.21
28
2026-Q1
Decreased
367,906
-37.3%
$5.2M0.0%$15.73
0
2025-Q4
Increased
586,636
+2.6%
$6.1M0.0%$9.92
28
2025-Q3
Increased
571,738
+0.9%
$3.4M0.0%$5.97
27
2025-Q2
Decreased
566,781
-1.5%
$4.3M0.0%$7.76
0
2025-Q1
Decreased
575,531
-0.8%
$4.4M0.0%$8.02
0
2024-Q4
Increased
580,136
+3.4%
$7.1M0.0%$12.20
28
2024-Q3
Increased
560,873
+1.1%
$9.4M0.0%$17.19
28

Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, STATE STREET CORP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used